NYSE:BMY

Bristol-myers Squibb Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy BMY

*Your capital is at risk

$64.84

+0.120 (+0.185%)

At Close: Aug 10, 2026

Bristol-Myers Squibb Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 27.79. In total, the insiders bought 715.68M and sold 128.8K BMY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	27.79
● Buy	715.68M shares
● Sell	128.8K shares
64% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Apr 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 27.79. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	4 495 Value: $270.3K
Mar 10, 2026 Buy	Performance Shares A-Award	Short Bartie Wendy EVP, Corporate Affairs	Officer	9 796 Value: $589.0K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Short Bartie Wendy EVP, Corporate Affairs	Officer	2 207 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Short Bartie Wendy EVP, Corporate Affairs	Officer	828 Value: $49.8K
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	749 Value: $45.0K
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	639 Value: $38.4K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Short Bartie Wendy EVP, Corporate Affairs	Officer	72 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Short Bartie Wendy EVP, Corporate Affairs	Officer	205 Value: $12.3K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	9 702 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	5 145 Value: $309.4K
Mar 10, 2026 Buy	Market Share Units A-Award	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	21 224 Value: $1.28M
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	3 293 Value: $198.0K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	356 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	1 503 Value: $90.4K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	275 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	1 112 Value: $66.9K
Mar 10, 2026 Buy	Market Share Units M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	3 293 Value: $198.0K
Mar 10, 2026 Buy	Performance Shares M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	19 760 Value: $1.19M
Mar 10, 2026 Buy	Market Share Units M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	2 448 Value: $147.2K
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Plenge Robert M EVP, Chief Research Officer	Officer	14 052 Value: $844.9K
Mar 10, 2026 Buy	Performance Shares A-Award	Plenge Robert M EVP, Chief Research Officer	Officer	26 939 Value: $1.62M
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Plenge Robert M EVP, Chief Research Officer	Officer	6 900 Value: $0
Mar 10, 2026 Buy	Market Share Units M-Exempt	Plenge Robert M EVP, Chief Research Officer	Officer	2 342 Value: $140.8K
Mar 10, 2026 Buy	Performance Shares M-Exempt	Plenge Robert M EVP, Chief Research Officer	Officer	14 052 Value: $844.9K
Mar 10, 2026 Buy	Market Share Units M-Exempt	Plenge Robert M EVP, Chief Research Officer	Officer	1 107 Value: $66.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BRISTOL-MYERS SQUIBB COMPANY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th...

Read Full Profile Here